Anika Therapeutics Inc. · NASDAQ:ANIK
Anika Therapeutics — Q2 2026 Earnings Presentation
16 slides from Anika Therapeutics's earnings presentation, Jul 29, 2026
Slide 1: Q2 2026 Earnings Call
Q2 2026 EARNINGS CALL JULY 29, 2026 Anika. Restore Active Living.
Slide 2: Safe Harbor Statements
SAFE HARBOR STATEMENTS Cautionary Note on Forward-looking Statements The statements made in, and during the course of, this presentation that are not statements of historical fact, including those related to the Company’s commercial capabilities, initiatives and production, its product pipeline and
Slide 3: Company Highlights
COMPANY HIGHLIGHTS STRATEGY DRIVING GROWTH, OPERATIONAL DISCIPLINE AND PIPELINE ADVANCEMENT Growth Operational Discipline New Product Pipeline • Commercial Channel revenue increased • Gross margin expanded more than 14 17% year-over-year to $13.9M, driven by points year-over-year to 65%, driven by •
Slide 4: Integrity Unit Sales Update
INTEGRITY UNIT SALES UPDATE Integrity Unit Sales Since Launch 700 2500 600 2000 500 1500 400 • Global units and surgeries increased both sequentially and year- over-year, generating approximately $2M of revenue for the 300 1000 second consecutive quarter 200 • Continued double-digit growth in new su
Slide 5: Q2 2026 Financial Highlights
Q2 2026 FINANCIAL HIGHLIGHTS 2Q26 Continuing Operations Highlights $M, except per share data CONTINUING OPERATIONS • Revenue of $32.6M increased 16% year-over-year, Q2 Financial Results 2026 VPY driven by continued strength in both the Commercial and OEM Channels Revenue $32.6 16% • Commercial Chann
Slide 6: 2026 and Long-Term Revenue Guidance
2026 AND LONG-TERM REVENUE GUIDANCE +5% to 0% to $121 $120 Updates to Prior Guidance $114 +10% +5% $113 $107 • Raising 2026 OEM Revenue to Revenue $95 reflect stronger Monovisc volume 0% Flat to • Raising 2026 Adjusted EBITDA to to Modestly 85 78 64 13%-17% to account for improved 82 +5% Lower opera
Slide 7: Strategies to Deliver Shareholder Value
3 STRATEGIES TO DELIVER SHAREHOLDER VALUE • Accelerating growth driven by strong Commercial Channel momentum • Strengthening operational discipline with improved productivity and disciplined expense control • Advancing a Robust New Product Pipeline with Hyalofast, Cingal, the Integrity platform, and
Slide 8: Non-GAAP Reconciliation and Supplemental Data
NON-GAAP RECONCILIATION AND SUPPLEMENTAL DATA 8
Slide 9: Statement of Operations
STATEMENT OF OPERATIONS @ANIKA Revenue Cost of Revenue Gross Profit Operating expenses: Research and development Seling, general and administrative Total operating expenses Income (loss) from operations Interest and other income (expense), net Income (loss) before income taxes Provision for income t
Slide 10: Balance Sheet
BALANCE SHEET Aa erp Consolidated Balance Sheets {in thousands, except per share data) (unaudited) June 30, December 31, ASSETS 2026 2025 Cument assets: Cash and cash equivalents: $ 38412 $ 57481 Accounts receivable, net 29962 23690 Inventories, et 22565 18787 Prepaid expenses and other curent asset
Slide 11: Cash Flow Statement
CASH FLOW STATEMENT @ANIKA ‘Anika Therapeutics, Inc. and Subsidiaries ‘Consolidated Statements of Cash Flows (la thousands) (unaudited) (Cash flows fram operating activities: Net oss Nan-cash operating lene cost, Deferred income taxes Interett income on nates receivable Gain onsale ofasets ‘Changes
Slide 12: Reconciliation Tables – GAAP Net Income (Loss) to Adjusted EBITDA
RECONCILIATION TABLES – GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA 12
Slide 13: Reconciliation Tables – GAAP Net Income to Adjusted Net Income
RECONCILIATION TABLES – GAAP NET INCOME TO ADJUSTED NET INCOME 13
Slide 14: Reconciliation Tables – GAAP EPS to Adjusted EPS
RECONCILIATION TABLES – GAAP EPS TO ADJUSTED EPS 14
Slide 15: Revenue by Channel
REVENUE BY CHANNEL Anika Therapeutics, Inc. and Subsidiaries Revenue by Product Family {in thousands, except percentages) (unaudited) For the Three Months Ended June 30, For the Six Months Ended June 30, 2026 2025 $ change %change 2026 2025 $ change % change OEM Channel $ 18705 «=$ «(16300 «$= (2,36
Slide 16: @ANIKA
@ANIKA